| Product Name | SB-431542 | 
|---|---|
| CAS | 301836-41-9 | 
| Formula | C22H16N4O3 | 
| MW | 384.39 | 
| Appearance | white to off-white solid powder | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 10 mg | In-stock | $300.00 | Visible after login | |
| 20 mg | In-stock | $400.00 | Visible after login | |
| 50 mg | In-stock | $950.00 | Visible after login | 
| Product Name | SB-431542 | 
|---|---|
| CAS | 301836-41-9 | 
| Formula | C22H16N4O3 | 
| MW | 384.39 | 
| Appearance | white to off-white solid powder | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
SB-431542 is a novel small molecule inhibitor of the type I TGF-beta receptor, on a panel of human malignant glioma cell lines. SB-431542 blocked the phosphorylation and nuclear translocation of the SMADs, intracellular mediators of TGF-beta signaling, with decreased TGF-beta-mediated transcription. Furthermore, SB-431542 inhibited the expression of two critical effectors of TGF-beta-vascular endothelial growth factor and plasminogen activator inhibitor-1.